Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1999 | 1 |
2009 | 1 |
2010 | 1 |
2011 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Cone-rod dystrophy 17"
Page 1
Analysis of Early Cone Dysfunction in an In Vivo Model of Rod-Cone Dystrophy.
Int J Mol Sci. 2020 Aug 22;21(17):6055. doi: 10.3390/ijms21176055.
Int J Mol Sci. 2020.
PMID: 32842706
Free PMC article.
Retinitis pigmentosa (RP) is a generic term for a group of genetic diseases characterized by loss of rod and cone photoreceptor cells. Although the genetic causes of RP frequently only affect the rod photoreceptor cells, cone photoreceptors become stre …
Retinitis pigmentosa (RP) is a generic term for a group of genetic diseases characterized by loss of rod and cone photorecepto …
Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations.
Sun X, Pawlyk B, Xu X, Liu X, Bulgakov OV, Adamian M, Sandberg MA, Khani SC, Tan MH, Smith AJ, Ali RR, Li T.
Sun X, et al.
Gene Ther. 2010 Jan;17(1):117-31. doi: 10.1038/gt.2009.104. Epub 2009 Aug 27.
Gene Ther. 2010.
PMID: 19710705
Free PMC article.
Gene defects in AIPL1 cause a heterogeneous set of conditions ranging from Leber's congenital amaurosis (LCA), the severest form of early-onset retinal degeneration, to milder forms such as retinitis pigmentosa (RP) and cone-rod dystrophy. In mice, null and h …
Gene defects in AIPL1 cause a heterogeneous set of conditions ranging from Leber's congenital amaurosis (LCA), the severest form of early-on …
Item in Clipboard
Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial.
Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R.
Siqueira RC, et al.
Retina. 2011 Jun;31(6):1207-14. doi: 10.1097/IAE.0b013e3181f9c242.
Retina. 2011.
PMID: 21293313
Clinical Trial.
PURPOSE: To evaluate the short-term (10 months) safety of a single intravitreal injection of autologous bone marrow-derived mononuclear cells in patients with retinitis pigmentosa or cone-rod dystrophy. METHODS: A prospective, Phase I, nonrandomized, open-lab …
PURPOSE: To evaluate the short-term (10 months) safety of a single intravitreal injection of autologous bone marrow-derived mononuclear cell …
Item in Clipboard
Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration.
Chong NH, Alexander RA, Waters L, Barnett KC, Bird AC, Luthert PJ.
Chong NH, et al.
Invest Ophthalmol Vis Sci. 1999 May;40(6):1298-305.
Invest Ophthalmol Vis Sci. 1999.
PMID: 10235570
PURPOSE: To determine whether ciliary neurotrophic factor (CNTF) or brain-derived neurotrophic factor (BDNF) treatment leads to long-term photoreceptor survival in hereditary retinal degeneration. METHODS: An autosomal dominant feline model of rod-cone dystrophy …
PURPOSE: To determine whether ciliary neurotrophic factor (CNTF) or brain-derived neurotrophic factor (BDNF) treatment leads to long-term ph …
Item in Clipboard
Cite
Cite